![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
THE AGILE 3+ AND 4 SCORES MOST ACCURATELY PREDICT MAJOR ADVERSE LIVER OUTCOMES AND DEATH COMPARED TO LIVER STIFFNESS MEASUREMENT AND FIBROSCAN- AST SCORE
|
|
|
AASLD 2022 Nov 4-8
Emily Truong, Internal Medicine, Cedars- Sinai Medical Center, Jeffrey Gornbein, UCLA, Ju Dong Yang, Karsh Division of Gastroenterology and Hepatology, Cedars Sinai Medical Center; Comprehensive Transplant Center, Cedars Sinai Medical Center, Stephen A. Harrison, Radcliffe Department of Medicine, University of Oxford, Naim Alkhouri, Arizona Liver Health and Mazen Noureddin, Houston Methodist Hospital
![1117221](../images/111722/111722-9/1117221.gif)
![1117222](../images/111722/111722-9/1117222.gif)
![1117223](../images/111722/111722-9/1117223.gif)
![1117224](../images/111722/111722-9/1117224.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|